JAGSONPAL Pharmaceuticals Ltd. reported unaudited standalone earnings results for the second quarter and half year ended September 30, 2016. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 400.190 million against INR 329.696 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 14.994 million against INR 17.712 million a year ago. Profit from ordinary activities before tax was INR 6.293 million against INR 5.985 million a year ago. Net profit for the period was INR 5.033 million against INR 4.395 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 0.19 against INR 0.17 a year ago. For the half year, the company reported net sales/income from operations (net of excise duty) of INR 801.292 million against INR 699.571 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 32.495 million against INR 36.070 million a year ago. Profit from ordinary activities before tax was INR 14.310 million against INR 12.300 million a year ago. Net profit for the period was INR 11.447 million against INR 9.040 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 0.44 against INR 0.35 a year ago.